v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Stockholders' Deficit
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling interest
Total
Beginning balance (in shares) at Dec. 31, 2023   13,338,437          
Beginning balance at Dec. 31, 2023 $ (9,456,219) $ 1,334 $ 13,288,174 $ (22,860,351) $ 114,624 $ (26,345) $ (9,482,564)
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense 41   41       41
Other comprehensive income 10,518       10,518   10,518
Net loss (2,605,710)     (2,605,710)   2,337 (2,603,373)
Ending balance (in shares) at Mar. 31, 2024   13,338,437          
Ending balance at Mar. 31, 2024 (12,051,370) $ 1,334 13,288,215 (25,466,061) 125,142 (24,008) (12,075,378)
Beginning balance (in shares) at Dec. 31, 2024   29,093,289          
Beginning balance at Dec. 31, 2024 (25,104,263) $ 2,910 20,152,919 (45,426,099) 166,007 1,317,756 (23,786,507)
Increase (Decrease) in Stockholders' Equity              
3(a)(10) Settlement Agreement (Note 5) (in shares)   3,674,558          
3(a)(10) Settlement Agreement (Note 5) 3,077,252 $ 367 3,076,885       3,077,252
Issuance of common stock to settle share reset derivative liabilities (in shares)   2,737,168          
Issuance of common stock to settle share reset derivative liabilities 1,712,005 $ 274 1,711,731       1,712,005
Other comprehensive income 10,781       10,781   10,781
Net loss (7,018,410)     (7,018,410)   41,071 (6,977,339)
Ending balance (in shares) at Mar. 31, 2025   35,505,015          
Ending balance at Mar. 31, 2025 $ (27,322,635) $ 3,551 $ 24,941,535 $ (52,444,509) $ 176,788 $ 1,358,827 $ (25,963,808)